期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Arabidopsis BIG1 and BIG5 are crucial for male gametophyte transmission
1
作者 Yiping Suo Jirong Huang 《Journal of Integrative Plant Biology》 SCIE CAS CSCD 2019年第9期981-986,共6页
Arabidopsis contains five Brefeldin Ainhibited guanine nucleotide exchange factors(BIGs),which play a critical role in vesicle biogenesis for protein traffic from the Golgi to the plasma membrane.Biological processes ... Arabidopsis contains five Brefeldin Ainhibited guanine nucleotide exchange factors(BIGs),which play a critical role in vesicle biogenesis for protein traffic from the Golgi to the plasma membrane.Biological processes regulated by BIG1-BIG4 are postulated to be distinct from those by BIG5. However, we show that the self-pollinated BIG1+/- big5 silique do not produce homozygous seeds, and some pollen tubes from BIG1+/- big5 anthers grew slowly in vitro and failed to target nearby ovules in vivo. We identified the big1 big5 homozygote from the progeny of BIG1+/- big5 plants transformed with BIG5, whose expression is driven by a pollen-specific promoter p Lat52, indicating that male gametophyte transmission is blocked in the double mutant. Confocal microscopy indicated that BIG1 and BIG5 are co-localized in trans Golgi network. Thus,our data indicate that BIG1 and BIG5 are crucial for male gametophyte transmission. 展开更多
关键词 ARABIDOPSIS big1 and BIG5 MALE GAMETOPHYTE TRANSMISSION
原文传递
胃癌及胃癌前病变患者中外周血Big内皮素-1检测的临床意义 被引量:3
2
作者 陈卫珍 滕小军 沈志祥 《检验医学》 CAS 北大核心 2007年第3期335-338,共4页
目的探讨Big内皮素-1(ET-1)在胃癌及胃癌前病变患者外周血中变化的意义。方法应用酶联免疫吸附试验(ELISA)检测50例进展期胃癌、8例早期胃癌、22例胃溃疡、30例慢性萎缩性胃炎患者及20名正常对照者血浆Big ET-1的水平,应用免疫组化法检... 目的探讨Big内皮素-1(ET-1)在胃癌及胃癌前病变患者外周血中变化的意义。方法应用酶联免疫吸附试验(ELISA)检测50例进展期胃癌、8例早期胃癌、22例胃溃疡、30例慢性萎缩性胃炎患者及20名正常对照者血浆Big ET-1的水平,应用免疫组化法检测胃癌及癌前病变中Big ET-1蛋白的表达。结果<2.5 cm胃溃疡组、慢性萎缩性胃炎及早期胃癌、进展期胃癌组的血浆Big ET-1水平均显著高于正常对照组(P<0.01),其中进展期胃癌组的Big ET-1水平显著高于<2.5 cm胃溃疡组、慢性胃炎及早期胃癌组(P<0.01),伴随淋巴结转移组血浆Big ET-1水平显著高于无淋巴结转移者(P<0.01)。胃癌组Big ET-1蛋白的阳性表达率与不典型增生者差异有统计学意义(P<0.01)。结论Big ET-1在外周血中的水平升高是胃癌发生的早期事件,并随着肿瘤的进展而升高。胃癌患者血浆Big ET-1水平的检测可作为预测早期淋巴结转移的潜在指标。 展开更多
关键词 胃癌 Big内皮素-1 癌前病变
下载PDF
胃癌患者术前血浆Big内皮素1水平检测的临床意义
3
作者 滕小军 刘荣 +2 位作者 张智翔 贺降福 沈志祥 《癌症》 SCIE CAS CSCD 北大核心 2008年第1期88-91,共4页
背景与目的:内皮素是一种作用强大的血管收缩短肽,研究表明它还参与肿瘤细胞的分裂、凋亡、血管形成、侵袭与转移。Big内皮素1(Bigendothelin-1,Big ET-1)a是内皮素的前体物,具有更强的稳定性,常作为肿瘤进展与预后的标志物。本研究通... 背景与目的:内皮素是一种作用强大的血管收缩短肽,研究表明它还参与肿瘤细胞的分裂、凋亡、血管形成、侵袭与转移。Big内皮素1(Bigendothelin-1,Big ET-1)a是内皮素的前体物,具有更强的稳定性,常作为肿瘤进展与预后的标志物。本研究通过检测胃癌患者术前外周血中Big ET-1的水平及其蛋白在胃癌组织中的表达,探讨Big ET-1与胃癌的发展、术后复发和生存率的关系。方法:应用ELISA法检测118例胃癌患者及20例健康对照组的血浆BigET-1的水平。同时应用免疫组化法检测118例胃癌及癌旁组织中Big ET-1蛋白的表达。并分析其与胃癌术后复发和预后的关系。结果:进展期胃癌的血浆Big ET-1水平(5.78±1.85)ng/L显著高于早期胃癌的(3.13±1.72)ng/L(P=0.026)及健康对照组的(2.46±0.59)ng/L(P=0.008),早期胃癌与正常对照组间差异无统计学意义(P=0.086)。伴随淋巴结转移患者的血浆Big ET-1水平(6.13±2.34)ng/L显著高于无淋巴结转移者的(4.25±1.65)ng/L(P=0.006)。胃癌Ⅱ、Ⅲ、Ⅳ期患者Big ET-1水平显著高于Ⅰ期患者,但Ⅱ、Ⅲ、Ⅳ期者之间差异无统计学意义。胃癌患者术前Big ET-1高水平组的复发率(84.6%)显著高于较低水平组(60.9%)(P=0.034);其2年生存率较低水平组低(38.5%vs.56.5%,P=0.017)。Ⅱ、Ⅲ、Ⅳ期胃癌患者的Big ET-1蛋白阳性表达率显著高于Ⅰ期患者,Ⅱ、Ⅲ、Ⅳ期之间的差异无统计学意义。结论:胃癌患者术前血浆Big ET-1水平随肿瘤的进展而升高,与胃癌的发展、浸润及转移相关。术前血浆Big ET-1水平可作为判断胃癌患者病情程度及预后的一项指标。 展开更多
关键词 胃肿瘤 Big内皮素1 预后
下载PDF
Plasma big endothelin-1 is an effective predictor for ventricular arrythmias and end-stage events in primary prevention implantable cardioverter-defibrillator indication patients 被引量:1
4
作者 Xiao-Yao LI Shuang ZHAO +6 位作者 Xiao-Han FAN Ke-Ping CHEN Wei HUA Zhi-Min LIU Xiao-Di XUE Bin ZHOU Shu ZHANG 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2020年第7期427-433,共7页
Objective To investigate whether plasma big endothelin-1(ET-1) predicts ventricular arrythmias(VAs) and end-stage events in primary prevention implantable cardioverter-defibrillator(ICD) indication patigents. Methods ... Objective To investigate whether plasma big endothelin-1(ET-1) predicts ventricular arrythmias(VAs) and end-stage events in primary prevention implantable cardioverter-defibrillator(ICD) indication patigents. Methods In total, 207 patients fulfilling the inclusion criteria from Fuwai Hospital between January 2013 and December 2015 were retrospectively analyzed. The cohort was divided into three groups according to baseline plasma big ET-1 tertiles: tertile 1(< 0.38 pmol/L, n = 68), tertile 2(0.38–0.7 pmol/L, n = 69), and tertile 3(> 0.7 pmol/L, n = 70). The primary endpoints were VAs. The secondary endpoints were end-stage events comprising all-cause mortality and heart transplantation. Results During a mean follow-up period of 25.6 ± 13.9 months, 38(18.4%) VAs and 78(37.7%) end-stage events occurred. Big ET-1 was positively correlated with NYHA class(r = 0.165, P = 0.018), serum creatinine concentration(Scr;r = 0.147, P = 0.034), high-sensitivity C-reactive protein(hs-CRP;r = 0.217, P = 0.002), Lg NT-pro BNP(r = 0.463, P < 0.001), left ventricular end diastolic diameter(LVEDD;r = 0.234, P = 0.039) and negatively correlated with left ventricular ejection fraction(LVEF;r =-0.181, P = 0.032). Kaplan-Meier analysis showed that elevated big ET-1 was associated with increased risk of VAs and end-stage events(P < 0.05). In multivariate Cox regression models, big ET-1 was an independent risk factor for VAs(hazard ratio(HR) = 3.477, 95% confidence interval(CI): 1.352–8.940, P = 0.010, tertile 2 vs. tertile 1;HR = 4.112, 95% CI: 1.604–10.540, P = 0.003, tertile 3 vs. tertile 1) and end-stage events(HR = 2.804, 95% CI: 1.354–5.806, P = 0.005, tertile 2 vs. tertile 1;HR = 4.652, 95% CI: 2.288–9.459, P < 0.001, tertile 3 vs. tertile 1). Conclusions In primary prevention ICD indication patients, plasma big ET-1 levels can predict VAs and end-stage events and may facilitate ICD-implantation risk stratification. 展开更多
关键词 Big endothelin-1 End-stage events Implantable cardioverter-defibrillator implantation Primary prevention Ventricular arrythmias
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部